Industry Policy Committee


To promote initiatives (outside regulatory and reimbursement) which impact on industry development and sustainability and healthcare policy. 


  1. Develop policy positions and engage with stakeholders on the following:  
  • Digital healthcare agenda including cybersecurity, the electronic patient record, mobile healthcare and registries.
  • Supply chain issues, including traceability of medical devices, and regularly engaged with GS1 Australia. 
  • MTP Connect initiatives, R&D, clinical trials and commercialisation. 
  • Industry input into NSW Knowledge Hun projects to support the MedTech sector. 
  • Industry input into export initiatives and issues. 
  1. Monitor the implementation of the $30 million grant for SMEs under the MTAA‐Government Agreement. 


MTAA Secretary: Merrilyn Clancy, Senior Policy Officer

Member Name


Daniel Kildea (Chair)

Johnson & Johnson

Ross Lane

Cook Medical

Matthew Malone


Paul Davies


Damon Mogridge


Jane Crowe

Roche Diabetes Care Australia

Simon Williamson

Edwards Lifesciences

Rebecca Cortiula

Varian Medical Systems

Kate King


Michael Reynolds


Kirk Kikirekov

Prospitalia h-trak

George Sidis

IDE Group

Geethu Roshan Verghese

Boston Scientific

Naeema Mohamed

Zimmer Biomet

Tansy Michael

Fresenius Medical Care


Meeting dates for 2021: 

  • Monday, 1 February
  • Thursday, 18 March
  • Tuesday, 18 May
  • Thursday, 22 July
  • Wednesday, 15 September
  • Monday, 8 November